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The effect of educational intervention  
on medication adherence behaviour in  
patients with type 2 diabetes:  
application of social marketing model
AbSTRACT
background. Patient’s adherence to the medication 
regimen leads to successful treatment in diabetic 
patients and a reduction in the severity of complica-
tions. Educational intervention is needed to improve 
behaviour and change attitudes in diabetic patients. 
This study aimed to determine the effect of educational 
intervention based on social marketing on promoting 
medication adherence behaviour in type 2 diabetic 
patients.
Methods. Using random sampling, 110 diabetic pa-
tients covered by health centres in Qazvin in the form 
of experimental and control groups participated in a 
randomized controlled trial. Data collection tools in-
cluded demographic questions and valid scales related 
to psychological constructs and drug adherence. The 
intervention program consisted of 5 group training 
sessions for 90-60 minutes based on the initial needs 
assessment and the theoretical framework of the social 
marketing model for the experimental group. Also, 
a purposeful educational pamphlet, two sessions of 
telephone counselling, and educational messages via 
mobile phone were provided in addition to the group 
training program for patients in the experimental 
group. Data were analysed using SPSS software ver-
sion 25 and independent sample t-test, Chi-square test, 
One-way ANOVA, and covariance analysis.
Results. The mean age of study participants was (54.12 
± 8.22) years. Also, the average duration of diabetes 
was 5-10 years and 50% had primary education. The 
correlation between attitude, self-efficacy and subjec-
tive norm with medication adherence behaviour was 
significant (P < 0.05). After the intervention based 
on the social marketing model, the mean of the con-
structs of attitude (39), self-efficacy (31), awareness 
(66), subjective norm (85), and medication adherence 
(49) increased significantly in the experimental group.
Conclusion. Educational intervention based on social 
marketing could have a significant effect on improving 
medication adherence behaviour. The design of cognitive-
behavioural interventions based on social marketing 
is recommended to promote the health behaviours of 
diabetic patients. (Clin Diabetol 2021; 10; 4: 359–369)
Key words: social marketing, type 2 diabetes, 
medication adherence, education, attitude
Introduction 
Out of every five deaths in the world, four are 
attributed to non-communicable diseases including 
cardiovascular disease, cancer, chronic lung disease, 
and diabetes [1]. Diabetes is a chronic and metabolic 
disease characterized by elevated blood glucose levels 
and is recognized as a major public health challenge 
[2, 3]. Persistently high blood glucose levels can lead to 
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complications including serious cardiovascular disease, 
kidney disease, blindness, peripheral nerve problems, 
retinopathy and neuropathy, dental problems, and 
amputation [4, 5]. In 2019, the cost of diabetes at the 
World Health Organization is $ 760 billion and is pro-
jected to reach $ 825 billion by 2030 and $ 845 billion 
by 2045 [6, 7]. According to the IDF, in 2019, the preva-
lence of diabetes was 9.3% in the world, which is an 
increase compared to 2017, when the prevalence was 
8.8%. It is estimated that the prevalence of diabetes 
in 2030 will reach 10.2% and in 2045, 10.9. The high-
est prevalence is related to the Eastern Mediterranean 
region, where the prevalence is 12.2% in 2019 [4, 8]. 
The prevalence of diabetes in Iran, which is part of the 
Eastern Mediterranean region, has shown 14.6–11.3%. 
Also, in Qazvin, an average of 8.5% of people have dia-
betes [9, 10]. About 90% of the prevalence of diabetes 
is related to type 2 diabetes. Risk factors for diabetes 
include genetic factors, inactivity, poor nutrition, high 
blood pressure, and high cholesterol levels, and stress 
[11]. Despite advances in pharmacological interventions 
to control type 2 diabetes, self-care education, which 
includes physical activity, a healthy diet, medication 
adherence, self-monitoring of blood sugar, and foot 
care, is beneficial and effective in controlling diabetes 
[3, 12]. According to the definition of the World Health 
Organization; Drug adherence, the degree of obedience 
to medical advice, medication use, and lifestyle changes 
that reduce costs and hospitalization and control 
a patient’s blood sugar [13, 14]. Over time, patient 
adherence decreases so that after three months, 21% 
and after 6 months, 44% of patients refuse to take the 
medication [15]. The World Health Organization divides 
the factors of adherence to medication adherence in 
chronic patients into five categories, which include 
economic and social factors, the health team, and the 
patient care system, and treatment-related factors. 
Factors related to the patient can be changed by using 
education and increasing knowledge [16, 17]. Patient 
education will lead to the improvement of psychologi-
cal factors affecting health behaviours such as how to 
use the medication [18]. Due to the complexity of 
patient’s behaviour, it is necessary to use theories and 
patterns of behaviour change in this field [19]. Social 
marketing is commonly used as an intervention strategy 
in global health to influence behaviours that benefit 
the health of individuals and communities [20]. The 
function of this strategy was effective in the field of 
healthy eating, control of AIDS, and reducing smoking, 
which was used to correct undesirable behaviours and 
change attitudes [21]. In a social marketing interven-
tion, the following components should be considered: 
1. Behavioural change: Setting goals to achieve behav-
iour change as the main focus of the intervention 2. 
Evolutionary research: Using research to understand 
the needs of the target audience, pre-test interventions, 
and monitoring their performance, which is an essential 
part of the intervention 3- Segmentation: Segmentation 
of the audience based on common characteristics 4- 
Marketing mix: which is known as 4P. The 4P concept 
consists of four sub-dimensions: Product; Includes ideas 
and behaviours acceptable to the audience, Price; per-
ceived costs and barriers related to the product; Place; 
where the customer has access to the product and its 
current information, Promotion; communication ele-
ments, and ways in which people become aware of the 
existence of a product or behaviour [22, 23]. Samad et 
al. [24] have also recommended the social marketing 
approach as a suitable framework for diabetes control 
programs and awareness-raising. Rogers et al. [25] used 
the social marketing campaign to raise the awareness 
and attitude of diabetic patients about diabetes pre-
vention. In Iran, in a review study, Rezaei-Pandari et al. 
[26] showed that health promotion interventions with 
a social marketing approach in relation to changing 
behaviours that require the use of a health product 
and access to facilities and also more influenced by 
individual attitudes and decisions; It can be associated 
with valuable success. Given the burden of diabetes 
and the need to reduce health costs, it is necessary to 
take steps to change the behaviour of diabetic patients. 
In this regard, this study was conducted to determine 
the effect of educational intervention on medication 
adherence of patients with type 2 diabetes referred to 
health centres in Qazvin using a social marketing model.
Material and methods
Type of study
The present study is a randomized controlled trial 
with clinical trial code IRCT20190927044901N1. This 
study was performed on patients with type 2 diabetes 
who were covered by health centres in Qazvin between 
February 2019 and July 2020. For the purpose of 
a double-blind approach, 1- the outcome evaluator and 
2- the analyst did not know the details of the groupings 
and knew the groups as A and B.
Sampling method
The study population was all patients with type 2 
diabetes who had a file in Qazvin Health Centre who 
were willing to participate in the study voluntarily. Us-
ing the multi-stage sampling method, 110 patients with 
type 2 diabetes were included in the study based on 
inclusion and exclusion criteria. First, out of 12 health 
centres in Qazvin, 4 centres were selected by simple 
random sampling. Considering the cultural, social, 
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and economic similarities and differences, Qazvin city 
was divided into two large regions and two centres 
were randomly selected from each region. A list of 
patients covered by each centre was prepared. Then, 
with the convenience Sampling method and based on 
the random number table, the sampling process was 
performed randomly from all 4 centres to reach the 
required sample size. The sample size was calculated 
using the mean difference formula was calculated by 
considering the 95% confidence level, 5% percentage 
error, 80% test power. Finally, with a 10% drop, 55 
people were assigned to each of the experimental and 
control groups [27]. 
Inclusion and exclusion criteria
Inclusion criteria were: voluntary and informed 
participation, at least six months of diagnosis of type 2 
diabetes, age range 30 to 65 years, literacy for writing a 
history of type 2 diabetes medication treatment, living 
in Qazvin for at least the next 6 months, not participat-
ing in similar educational interventions in the last six 
months, having a mobile phone in patients or a family 
member to send a text message. Also, patients were 
excluded if they had the following: advanced physical 
consequences and complications due to diabetes, hav-
ing mental disorders such as depression (based on the 
doctor’s diagnosis and recorded in the patient’s file) 
that prevent the correct response or active participation 
in the research, having gestational diabetes during the 
research period, having type 1 diabetes, hospitalization 
history during the study, suffering from uncontrolled 
underlying diseases such as hypertension above 130.90 
mm Hg with drug use, drug dependence.
Data collection tools
The required data were collected using a self-report 
questionnaire in two basic stages and 3 months after 
the educational intervention. The questionnaire con-
sisted of the following sections:
A) Background information, demographic informa-
tion and medical records: including questions on 
age, sex, education, economic status, marital sta-
tus, occupation, weight, body mass index, cardio-
vascular disease, kidney and duration of illness.
B) Morisky Medication Adherence Scale, which consists 
of 8 questions. 7 questions with two-choice expres-
sions (zero = yes and one = no) and one question 
with five-choice expressions (from zero = never up 
to 4 = Always). A score of 6 or higher is considered 
a desirable adherence to treatment. 
 The Morisky Medication Adherence Questionnaire 
has been used extensively in domestic and foreign 
studies and its psychometric properties have been 
confirmed [28, 29]. Also, by completing a ques-
tionnaire with a sample size of 20 patients with an 
interval of two weeks, the reliability of this ques-
tionnaire was calculated in the present study. The 
coefficient of retest was 0.78 and Cronbach’s alpha 
coefficient was 0.83 which confirmed the internal 
consistency coefficient. The sample was randomly 
selected from the main population and did not par-
ticipate in the final study.
C) Diabetic Patient’s Awareness Scale: The scale con-
sisted of 16 questions that participants were asked 
to answer the questions using the options Yes, No 
and I do not know. Each correct answer was given 
a score of one and the wrong answers and I do not 
know was also given a score of zero. The range of 
scores between zero and 16 higher scores indicates 
greater awareness. 
 Its validity and reliability have been measured in 
various studies [30]. Psychometric properties scale 
in the present study were also confirmed in the pi-
lot study (a = 0.79, r = 0.82).
D) Diabetic Patient’s Perceived Benefits Scale: The scale 
consists of 4 questions and participants were asked 
to answer questions based on a five-scale Likert 
scale (1 = strongly disagree to 5 = strongly agree). 
Responses ranged from 4 to 20 points, and higher 
scores indicated greater perceived benefits. 
 The internal consistency and its reliability have 
been confirmed in previous studies [31]. Also, the 
psychometric properties scale in the present study 
were confirmed (a = 0.93, r = 0.88).
E) Diabetic Patient’s Perceived Barriers Scale: This 
scale has 7 questions and participants were asked 
to answer the questions based on the five-scale 
Likert response range (1 = strongly disagree to 
5 = strongly agree). Questions ranged from 7 to 35. 
Higher scores indicated more perceived barriers. 
 The internal consistency and reliability have been 
confirmed in previous studies [31]. Cronbach’s al-
pha coefficient (a = 0.87) and retest coefficient 
(r = 0.84) were also calculated in the present study.
F) The specific self-efficacy scale for diabetic patients: 
It has 19 questions and participants were asked 
to answer questions based on the five-scale Likert 
(from 1= I am not at all confidential, 2 = somewhat 
confident and 3 = very confident). 
 Questions ranged from 19 to 57, and higher scores 
indicated greater self-efficacy. The internal consist-
ency has been confirmed (0.92) in Haghayegh. et al 
study. In the study of Slath et al., The internal con-
sistency and reliability of the questions (Cronbach’s 
alpha = 0.86) were confirmed [32, 33]. Also, Cron-
bach’s alpha coefficient (А = 0.78) and retest coef-
Clinical Diabetology 2021, Vol. 10, No 4
362
ficient (r = 0.80) in the present study confirmed 
the internal consistency and reliability, respectively.
G) Diabetic patient’s Subjective Norms Scale: It has 4 
questions and participants were asked to answer 
the questions based on the five-scale Likert response 
range (1 = strongly disagree to 5 = strongly agree). 
Higher scores indicated better social support. 
 Internal consistency and reliability have been con-
firmed in the study of Dashtian et al. [19]. In addi-
tion, Cronbach’s alpha coefficient (a = 0.96) and 
retest coefficient (r = 0.92) in the present study 
confirm the internal consistency and Were the reli-
ability.
Educational intervention
Steps of study and educational intervention: First, 
the literature was reviewed and the necessary resources 
were collected. Then the necessary coordination was 
made with the Vice Chancellor for Health and Research 
of Qazvin University of Medical Sciences. In the next 
step, telephone calls were made to the patients se-
lected to participate in the study for coordination, and 
after the initial introduction, they were given a brief 
explanation of the objectives of the study. If individuals 
expressed a desire to participate voluntarily, the neces-
sary coordination would be made based on a proposed 
timetable for participants to attend the selected health 
centres. The objectives of the study were described dur-
ing the patients’ attendance at the relevant centre. They 
were then reassured about voluntary participation in 
research, the confidentiality of information, anonymous 
questionnaires, the possibility of leaving the research 
at any time and other ethical issues were reassured. 
Informed and written agreement was obtained from 
all participants. Then, the research questionnaire was 
given to the patients in the presence of one of the 
members of the research group in the health centres. 
The presence of the researcher was to ensure complete 
and accurate answers to all questions, remove possi-
ble ambiguities and answer patients’ questions while 
completing the questionnaire, explained about other 
stages of the research and appreciated their participa-
tion. The approximate time to answer the questions 
was 25 minutes. In addition, due to the participation 
of the control group, the educational materials should 
be done in the form of pamphlets and a 2-hour face-
to-face meeting. An educational intervention based 
on the 4P social marketing model was presented to 
promote medication adherence behaviour in type 2 
diabetic patients based on psychological constructs in 
the experimental group (Table 1) [23].
After evaluating and analyzing the results of the 
questionnaire, interviews and evolutionary research, 
the educational program was conducted as a group 
discussion to develop educational interventions based 
on patient’s needs. After approval by the panel of ex-
perts in terms of importance, relevance, the complexity 
of the content and compliance of the content with the 
objectives, the training program was developed in the 
form of 5 sessions of face-to-face training for 60–90 
minutes two days a week (Fig. 1). Each training group 
consisted of 15 participants. To facilitate the presence 
of patients in the experimental group, classes were 
conducted in one day and two round in 10-9 AM and 
2-1 PM. In designing the training content and deter-
mining the training strategies, emphasis was placed on 
increasing awareness, changing attitudes, improving 
self-efficacy and subjective norms, promoting medica-
tion adherence behaviour and identifying and remov-
ing barriers. In this regard, verbal feedback, individual 
and face-to-face consultation with a physician in the 
field of diabetes, consultation with a psychiatrist and 
nutritionist (twice a week at 2–10 pm) was performed 
and family members also attended meetings to support 
the patient. In the fifth session, educational pamphlets 
were provided to the participants to review the materi-
als that were taught in the sessions. Patients who were 
successful in controlling diabetes were also invited to 
share their experiences. For example, a patient who had 
the retina problem and had improved with glycemic 
control, as well as a patient who had high blood sugar 
and was able to lower his blood sugar with suitable 
adherence, were invited to motivate other patients 
to promote medication adherence behaviour. After 
the face-to-face sessions to remind and re-learn the 
content presented in the class, educational videos 
and photos were continuously shared through What’s 
Up groups. Patients without access to WhatsApp also 
received training via SMS and phone call. After three 
months, the questionnaires were completed again by 
the samples. To thank the patients for participating in 
the study, the two groups were invited to perform A1C 
and FBS tests and the cost of the test was transferred 
to their account.
Statistical analysis
The obtained data were analysed using SPSS soft-
ware version 25. After ensuring the normal distribution 
of data using Kolmogorov-Smirnov test, Chi-square 
tests to evaluate the relationship between qualitative 
variables, independent sample t-test to compare quan-
titative variables between two independent groups and 
paired t-test to compare quantitative variable changes 
between groups before and after the intervention and 
analysis of variance to examine and compare a quan-
titative variable between three independent groups 
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and more were performed. The internal validity of the 
control study was also assessed using covariance analy-
sis. The significance level in the study was considered 
less than 0.05.
Ethical approval
This study is a master’s thesis that has been done by 
obtaining the necessary licenses from Qazvin University 
of Medical Sciences, the Vice-Chancellor for Health of 
Qazvin University of Medical Sciences and Qazvin Health 
Centre. (Ethics code: IR.QUMS.REC.1398.190)
Results
In the present study, the mean age of participants 
was generally 54.12 ± 8.22 years with an age range 
of 36 to 65 years. The mean weight of patients was 
74.25 ± 12.58 with a weight range of 50–115 kg. Other 
information is provided in Table 2.
The mean and standard deviation of psychological 
variables affecting medication adherence were com-
pared between experimental and control groups before 
the intervention. This comparison showed that there 
was no significant difference between the two groups 
in terms of these variables (Table 3). The mean and 
standard deviation of medication adherence behaviour 
before intervention in the experimental group was 3.45 
± 1.24 and in the control group was 3.64 ± 1.15. It 
showed that there was no significant difference be-
tween the two groups. The results of the independent 
sample t-test and comparison of medication adher-
ence’s mean between male patients 3.55 ± 1.21 and 
female patients 3.53 ± 1.17 did not show a significant 
difference between the two groups.
There is a correlation between demographic and 
psychological variables affecting medication adherence. 
Findings indicate that there is a significant correlation 
between medication adherence and attitude, subjective 
norms and self-efficacy. Attitude also had the strong-
est correlation coefficient with medication adherence 
behaviour (P < 0.05, r = 0.312) (Table 4).
Table 5 shows that the mean score of psychological 
variables in the experimental group increased signifi-
cantly (P < 0.001). According to the obtained squares, 
it can be stated that social marketing intervention 
training explains 38.2% of awareness mean’s variance, 
23.5% of attitude mean’s variance, 22.5% of self-
Table 1. Mixed social marketing model for diabetic patients’ medication adherence
P Definition Medication Adherence Application
Product Idea / Behaviour / Service Start taking diabetes medications  
(pills and insulin) on time
• Patients should first be aware of the problem 
through group discussion and training  
sessions (increase awareness to promote 
drug adherence behaviour)
• Execute medical orders on time, Taking  
medications controlling blood sugar
Price The value that consumers 
are forced to give up as 




• Lack of knowledge about the correct 
way to use the medications
• Forgetting medications
• Lack of motivation
• Interference with daily tasks
• The cost of medicines and lack  
of insurance coverage
• Lack of family support
• Side effects of medications
• Use of various medications
• Better price understanding to improve  
patient attitude and self-efficacy
• Training and counselling classes to overcome 
barriers to attitude and self-efficacy
Place A place where consumers 
gather to receive a product 
and be exposed to com-
munication
• All people with diabetes
• All family members
• All health centres and hospitals
• Doctors and medical staff
• Invite family members to participate in the 
training program (subjective norms) as the 
most important communication channel
• Consult a doctor
Promotion A tool for conveying mes-
sages and communicating 




Using various means of communication  
including mobile phones, daily text messages 
and holding telephone counselling classes, 
training by doctors, pamphlets and educational 
booklets to raise patients’ awareness
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efficacy mean’s variance, 44.5% of subjective norms 
mean’s variance and 31.8% of medication adherence 
mean’s variance in type 2 diabetic patients.
Discussion 
The present study was performed on 110 type 2 
diabetic patients living in Qazvin province. The effect 
of education on medication adherence in diabetic 
patients based on psychological constructs (attitude, 
self-efficacy, subjective norms, behavioural control and 
awareness) which is equivalent to social marketing 
4P (price, place, product, promotion) was evaluated 
for the first time in Iran. The results showed that the 
medication adherence’s mean (equivalent to product) 
increased to f = 49.94 after educational intervention 
in the experimental group. This finding is consistent 
with the study of Dashtiani et al. Which showed that 
medication adherence is at a desirable level in 76% 
of patients (19). The study of Gholamaliei et al. [34] 
which was a cross-sectional study, showed that 59.4% 
had poor adherence. It also stated that the most im-
portant reasons for medication non-adherence were 
patient-related beliefs, anxiety, self-efficacy and care 
group that was significantly associated with medication 
adherence (P < 0.05) [34]. In Hashemi et al.’s study, 
the most important strategy for improving medication 
Invite 110 patients 
with type 2 diabetes
Demographic information 
collection of all participants 
February 2019)
Random allocation 
of samples in two groups
55 people in the 
intervention group
55 people in the control group
Completion of pre-test questionnaire 
at the beginning of the intervention 
(February 2019) and FBS & A1C test
Completion of pre-test questionnaire 
at the beginning of the intervention 
(February 2019) and FBS & A1C test
Participating in ve 60-minute 
training sessions (March), 
two consecutive days a week 
with lm presentation
Sending daily educational 
messages and videos 
to patients and a family member
Free consultation with a doctor, 
psychologist and nutritionist 
two days a week (Monday and Tuesday)
Completion of post-test questionnaire 
three months after the start of the study 
(June and July 2020) and FBS & A1C test
Data analysis
Completion of post-test questionnaire 
three months after the start of the study 
(June and July 2020) and FBS & A1C test
Receive routine services 
from health centres
Excluded: 10 people
4 people with type 1 diabetes
3 people with gestational diabetes
3 people over the age of 65
Figure 1. Research process diagram
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adherence was to increase motivation and remove bar-
riers and concerns in diabetic patients (13). A study in 
southwestern Ethiopia, which was in line with the present 
study, showed the proportion of patients with low, me-
dium and high adherence was 24.9%, 2.9% and 37.37%, 
respectively. It was mentioned that having a desirable level 
of blood sugar control is associated with high adherence 
and also considered that an approach to increase patient 
awareness through educational intervention to promote 
medication adherence to be effective [35].
Table 2. Demographic characteristics of Diabetic patients participating in the study in the form of control and experi-
mental groups (n = 110)
Variable Experimental group Control group P value
Sex Male (30.9) 17 (27.3) 15 P = 0.834
Female (69.1) 38 (72.7) 40
Primary school (54.5) 30 (45.5) 25 c2 = 4.635
Education Middle school (18.2) 10 (20) 11 df = 4
High school (1.8) 1 (7.3) 4 P = 0/327
Diploma (25.5) 14 (12.7) 7
University (7.3) 4 (7.3) 4
Job Housewife (65.5) 36 (67.3) 37 c2 = 3.210
Retired (12.7) 7 (18.2) 10 df = 4
Employee (3.6) 2 (3.6) 2 P = 0.523
Self-employment (18.2) 10 (9.1) 5
Other (0/0) 0 (1.8) 1
Marital status Married (81.8) 45 (89.1) 49 c2 = 3.313
Single (1.8) 1 (0) 0 df = 3
Divorced (0) 0 (1.8) 1 P = 0.346
Other (16.4) 9 (9.1) 5
The economic status (Scheffer test) Excellent (0) 0 (0) 0 c2 = 0.584
Good (0) 0 (0) 0 df = 1
Medium (50.9) 28 (43.6) 24 P = 0.445
Weak  (49.1) 27 (56.4) 31
History of underlying diseases Cardiovascular disease (21.8) 12 (12.7) 7 c2 = 3.206
Kidney disease (1.8) 1 (0) 0 df = 3
High blood pressure (30.9) 17 (52.7) 29 P = 0.361
Other cases (45.5) 25 (34.5) 19
Duration of illness 12–6 (1.8) 1 (0) 0 c2 = 5.506
5–1 (10.9) 6 (25.5) 14 df = 3
10–5 (52.7) 29 (38.2) 21 P = 0.138
10 < (34.5) 19 (36.4) 20
Type of insurance Rural insurance (10.9) 6 (9.1) 5 c2 = 2.208
Social Security Insurance (40) 22 (43.6) 24 df = 4
Armed Forces Insurance (1.8) 1 (5/5) 3 P = 0.698
Health insurance (18.2) 10 (10.9) 6
Other (29.1) 16 (30.9) 17
Supplementary insurance Yes (6.43) 24 (45.5) 25 c2 = 0.037
No (56.4) 31 (54.5) 30 df = 1
P = 0.848
Family history Yes (70.9) 39 (70.9) 39 c2 = 0.000
No (29.1) 16 (29.1) 16 df = 1
P > 1.00
Type of treatment Pills (54.5) 30 (47.3) 26 c2 = 0.037
Insulin (7.3) 4 (12.7) 7 df = 2
Insulin / Pills  (38.2) 21 (40) 22 P = 0.569
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Based on the results, the average self-efficacy 
(equivalent to the price) increased to 31.05 after 
the educational intervention, which is in line with 
the results of the study of Zamani et al. with 30.38 
self-efficacy’s mean after the training. Therefore, the 
results indicate that education promotes self-efficacy 
and consequently medication adherence behaviour in 
patients [31]. A higher self-efficacy score indicates a 
person’s confidence in his ability to adhere to better 
behaviour. In the study of Mohamadinejad et al. [36] 
the mean self-efficacy was 167.60 after 8 weeks of edu-
cational intervention. In this case, one of the reasons 
for the high mean can be attributed to the sampling 
of hospitalized patients with a particular problem. The 
present study is consistent with a study in the United 
States with a self-efficacy score of 34.69 ± 4.93 and it 
is inferred from this study that to improve self-efficacy, 
physicians should address the concerns of low-health 
literate patients [37]. The results were consistent with 
a study in Laotian that showed self-efficacy was the 
most important factor in explaining the variance of 
medication adherence, so the need for an intervention 
program that includes methods to increase self-efficacy 
was recommended [38].
Other psychological constructs (equivalent to price) 
include patient’s attitudes (perceived barriers and 
benefits) to medication adherence. The mean score 
of attitude was 39.912 and the strongest correlation 
coefficient was related to attitude and medication 
adherence behaviour. The study of Gholamaliei et 
al., Which introduced patients’ attitudes as the most 
important factor of non-adherence, is consistent with 
this study [34]. In a study in the United States, bar-
rier constructs accounted for 44% of the variance on 
medication adherence behaviour, which showed that 
the most important barriers to medication adherence 
were the simultaneous use of several medications, 
medications side effects, forgetfulness, and it recom-
mended education to promote medication adherence 
behaviour [39]. Findings from a study in Singapore [40] 
showed that educational intervention via smartphones 
increases awareness and reduces attitudinal barriers in 
patients, which is consistent with the present study. The 
results of a study at the Joslin Diabetes Centre showed 
that psychologists have an important role in reducing 
emotional distress, improving knowledge and educa-
tion, so receiving advice from a doctors and diabetes 
nurse and, if necessary, using a psychiatrist can remove 
barriers and improve attitudes in patients [41].
The mean of subjective norms (equivalent to place) 
was f = 85.670. Also, the ETA coefficient showed 
that family members’ participation in the education 
process and communicating with the doctor, which 
is the most important source of information affect 
the patient’s behaviour. Meanwhile, 44.5% of the 
variance of the abstract norms variable is explained 
by educational intervention. The study of Gholamaliei 
et al. [34] showed that the most important sources of 
information were physicians and health workers (60%), 
family and friends (3%) and the least important were 
newspapers and magazines (0.6%). The present results 
Table 3. Comparison of the mean and standard deviation of 
psychological constructs affecting medication adherence 
in experimental and control groups before intervention






Awareness 19.63 ± 3.01 18.76 ± 2.57 0.104
Self-efficiency 46.25 ± 4.58 47.15 ± 3.75 0.267
Attitude 42.45 ± 3.95 42.43 ± 3.11 0.979
Subjective norms 18.23 ± 2.30 18.71 ± 2.33 0.287
Table 4. Pearson correlation coefficient between demographic and psychological variables affecting medication adherence
Variable 1 2 3 4 5 6 7 8 9
1 BMI 1
2 Age –0.229** 1
3 FBS –0.021 0.137 1
4 HbA1C 0.051 0.041 0.933 1
5 Awareness 0.035 0.166 0.308 0.046 1
6 Attitude –0.157 –0.018 –0.029 –0.122 –0.118 1
7 Subjective norms 0.070 –0.060 –0.115 –0.143 –0.155 0.163 1
8 Self-efficiency –0.131 0.034 –0.055 –0.362 –0.208* 0.226* 0.053 1
9 Medication adherence –0.140 0.094 –0.032 –0.075 –0.099 0.312* 0.192* 0.234* 1
*P < 0.05; **P < 0.01
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are consistent with a cross-sectional study in Brazil 
that introduces the patient’s children and physicians 
as important social and informational sources [42]. In 
line with the findings, a study in the Mexican-Americans 
promotes family support as an important source of 
information and facilitator of medication adherence. 
In this study, patients also stated that reminders from 
their spouses and children prevent them from giving 
up medications [43].
The mean awareness (equivalent to promotion) is 
66.219. In this regard, a study in Saudi Arabia reported 
an average of 51 to 75 [44]. In contrast, the mean 
awareness in a study in Pakistan was r = –0.036, p = 
0.404). One of the reasons for this discrepancy was 
patients’ lack of understanding of their disease, which 
could be due to the traditional nature of education and 
lack of patient feedback and lack of communication 
between the patients and physician [45]. This study 
showed that educating patients based on social market-
ing approach has a positive effect on all psychological 
constructs and this will lead to a change in medication 
Table 5. Covariance analysis of the effect of educational intervention on the mean of awareness, attitude, self-efficacy, 
subjective norms and medication adherence
Source of changes Sum of square df Mean of square F Sig Eta coefficient
Awareness 540.149 1 540.149 66.219 0.000 0.382
Group 1.371 1 1.371 0.168 0.683 0.002
Error 872.797 107 8.157
Total 32870.000 110
Source of changes Sum of square df Mean of square F Sig Eta coefficient
Attitude 1474.853 1 1474.853 39.912 0.000 0.235
Group 11.755 1 11.755 0.262 0.610 0.002
Error 4794.892 107 44.812
Total 268143.000 110
Source of changes Sum of square df Mean of square F Sig Eta coefficient
Self-efficiency 762.110 1 762.110 31.005 0.000 0.225
Group 5.139 1 5.139 0.209 0.648 0.002
Error 2630.109 107 24.580
Total 285363.000 110
Source of changes Sum of square df Mean of square F Sig Eta coefficient
Subjective norms 419.050 1 419.50 85.670 0.000 0.445
Group 8.708 1 8.708 1.780 0.185 0.016
Error 523.386 107 4.891
Total 46517.000 110
Source of changes Sum of square df Mean of square F Sig Eta coefficient
Medication adherence 79.568 1 79.568 49.944 0.000 0.318
Group 0.002 1 0.002 0.001 0.975 0.000
Error 170.466 107 1.593
Total 2566.563 110
adherence behaviour and better control of blood sugar 
by providing continuous counselling and educational 
messages.
Conclusion
The present study shows that educational interven-
tion based on social marketing, which was equivalent 
to the psychological constructs including awareness, 
self-efficacy, subjective norms, and attitude, promoted 
medication adherence behaviour in type 2 diabetic 
patients. The important point in the field of education 
through this approach was to identify the barriers and 
concerns of patients and remove these barriers through 
communication with the doctor. This increases self-
efficacy and thus promotes medication adherence be-
haviour in patients. Therefore, to develop a medication 
adherence program, it is necessary for physicians and all 
those patients who are in contact whit these patients to 
improve their skills by updating their information and 
participating in professional meetings in the field of 
social marketing. By this mean they can communicate 
Clinical Diabetology 2021, Vol. 10, No 4
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with the patient, follow up patients through electronic 
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